Lista de obras - Cliff G Robinson - Dominio Público Uruguay

A comparison of amplitude-based and phase-based positron emission tomography gating algorithms for segmentation of internal target volumes of tumors subject to respiratory motion.

artículo científico publicado en 2013

A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: a decision analysis

artículo científico publicado en 2011

A phase I study of temsirolimus and thoracic radiation in non--small-cell lung cancer

artículo científico publicado en 2013

Adherence of US Insurance Payer Policies to the American Society of Radiation Oncology Stereotactic Radiosurgery Model Policy

scientific article published on 28 January 2020

Adjuvant Chemotherapy Is Associated With Improved Survival in Locally Invasive Node Negative Non-Small Cell Lung Cancer

artículo científico publicado en 2017

Adjuvant Chemotherapy for Patients with T2N0M0 NSCLC

artículo científico publicado en 2016

Analysis of first recurrence and survival in patients with stage I non-small cell lung cancer treated with surgical resection or stereotactic radiation therapy

artículo científico publicado en 2014

Application of Critical Volume-Dose Constraints for Stereotactic Body Radiation Therapy in NRG Radiation Therapy Trials

artículo científico publicado en 2017

Assessing margin expansions of internal target volumes in 3D and 4D PET: a phantom study.

artículo científico publicado en 2014

Automated radiation therapy treatment plan workflow using a commercial application programming interface.

artículo científico

Bayesian network ensemble as a multivariate strategy to predict radiation pneumonitis risk

artículo científico publicado en 2015

Benchmark Credentialing Results for NRG-BR001: The First National Cancer Institute-Sponsored Trial of Stereotactic Body Radiation Therapy for Multiple Metastases.

artículo científico publicado en 2016

Brain Metastases at Presentation in Patients With Non-Small Cell Lung Cancer

artículo científico publicado en 2015

Clinical T2N0 Esophageal Cancer: Identifying Pretreatment Characteristics Associated With Pathologic Upstaging and the Potential Role for Induction Therapy.

artículo científico publicado en 2016

Clinical and Dosimetric Predictors of Acute Severe Lymphopenia During Radiation Therapy and Concurrent Temozolomide for High-Grade Glioma.

artículo científico publicado en 2015

Defining the Ideal Time Interval Between Planned Induction Therapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer.

artículo científico publicado en 2017

Delayed vertebral body collapse after stereotactic radiosurgery and radiofrequency ablation: Case report with histopathologic-MRI correlation

artículo científico

Distant intracranial failure in melanoma brain metastases treated with stereotactic radiosurgery in the era of immunotherapy and targeted agents

artículo científico publicado en 2017

Dosimetric predictors of chest wall pain after lung stereotactic body radiotherapy

artículo científico publicado en 2012

Effect of alternative temozolomide schedules on glioblastoma O(6)-methylguanine-DNA methyltransferase activity and survival.

artículo científico publicado en 2010

Heart Dose Is an Independent Dosimetric Predictor of Overall Survival in Locally Advanced Non-Small Cell Lung Cancer

artículo científico publicado en 2016

Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial

artículo científico publicado en 2016

Impact of concurrent chemotherapy with radiation therapy for elderly patients with newly diagnosed glioblastoma: a review of the National Cancer Data Base

artículo científico publicado en 2016

In Response to Treatment Outcomes in Stage I Lung Cancer: A Comparison of Surgery and Stereotactic Body Radiation Therapy.

artículo científico publicado en 2016

In reply to Gondi and Mehta.

artículo científico publicado en 2015

Independent test of a model to predict severe acute esophagitis.

artículo científico publicado en 2016

Institutional Enrollment and Survival Among NSCLC Patients Receiving Chemoradiation: NRG Oncology Radiation Therapy Oncology Group (RTOG) 0617.

artículo científico publicado en 2016

Intensity modulated radiation therapy for recurrent ovarian cancer refractory to chemotherapy.

artículo científico publicado en 2016

It's never too late: Smoking cessation after stereotactic body radiation therapy for non-small cell lung carcinoma improves overall survival

artículo científico publicado en 2015

Long-term survival and functional status of patients with low-grade astrocytoma of spinal cord.

artículo científico publicado en 2005

Management of atypical cranial meningiomas, part 2: predictors of progression and the role of adjuvant radiation after subtotal resection

artículo científico publicado en 2014

Modeling the impact of cardio-pulmonary irradiation on overall survival in NRG Oncology trial RTOG 0617

artículo científico publicado en 2020

Motion-specific internal target volumes for FDG-avid mediastinal and hilar lymph nodes

artículo científico publicado en 2013

Multi-Institutional Validation of a Knowledge-Based Planning Model for Patients Enrolled in RTOG 0617: Implications for Plan Quality Controls in Cooperative Group Trials

artículo científico publicado en 2018

Multidisciplinary Treatment for Stage IIIA Non-Small Cell Lung Cancer: Does Institution Type Matter?

artículo científico publicado en 2015

National Cancer Database Analysis of Proton Versus Photon Radiation Therapy in Non-Small Cell Lung Cancer

artículo científico publicado en 2016

National patterns of care and outcomes after combined modality therapy for stage IIIA non-small-cell lung cancer

artículo científico publicado en 2014

Neoadjuvant Chemotherapy versus Chemoradiation Prior to Esophagectomy: Impact on Rate of Complete Pathologic Response and Survival in Esophageal Cancer Patients

artículo científico publicado en 2016

Online Magnetic Resonance Image Guided Adaptive Radiation Therapy: First Clinical Applications.

artículo científico publicado en 2015

PET-based radiation therapy planning.

artículo científico publicado en 2014

Patterns of care in hilar node-positive (N1) non-small cell lung cancer: A missed treatment opportunity?

artículo científico publicado en 2016

Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non-small-cell lung cancer.

artículo científico publicado en 2013

Pneumonectomy for Clinical Stage IIIA Non-Small Cell Lung Cancer: The Effect of Neoadjuvant Therapy.

artículo científico publicado en 2015

Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the National Cancer Data Base

artículo científico publicado en 2015

Postoperative single-fraction radiation for prevention of heterotopic ossification of the elbow

artículo científico publicado en 2010

Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT)

artículo científico publicado en 2011

Predictors of individual tumor local control after stereotactic radiosurgery for non-small cell lung cancer brain metastases.

artículo científico publicado en 2014

Prospective study evaluating the use of IV contrast on IMRT treatment planning for lung cancer

artículo científico publicado en 2014

Radiation Treatment Time and Overall Survival in Locally Advanced Non-small Cell Lung Cancer.

artículo científico

Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases.

artículo científico publicado en 2016

Reply to C. Le Péchoux et al and B.S. Gill et al

artículo científico publicado en 2015

Response to "Is post-operative radiotherapy of any benefit after R0 resection for N2 disease?".

artículo científico publicado en 2015

Role for Surgical Resection in the Multidisciplinary Treatment of Stage IIIB Non-Small Cell Lung Cancer

artículo científico publicado en 2015

SV40 large tumor antigen (T antigen): database of mutants ⬇️

artículo científico publicado el 1 de enero de 1998

Simulated Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Oligometastatic Disease of the Abdomen and Central Thorax: Characterization of Potential Advantages.

artículo científico publicado en 2016

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two facto

artículo científico publicado en 2015

Stereotactic body radiation therapy for the treatment of early-stage minimally invasive adenocarcinoma or adenocarcnioma in situ (formerly bronchioloalveolar carcinoma): a patterns of failure analysis.

artículo científico publicado en 2013

Stereotactic body radiation therapy in the treatment of multiple primary lung cancers.

artículo científico publicado en 2012

The Metastatic Spine Disease Multidisciplinary Working Group Algorithms.

artículo científico publicado en 2015

The National Surgical Quality Improvement Program risk calculator does not adequately stratify risk for patients with clinical stage I non-small cell lung cancer

artículo científico publicado en 2015

The Role of Surgical Resection in Stage IIIA Non-Small Cell Lung Cancer: A Decision and Cost-Effectiveness Analysis.

artículo científico publicado en 2015

The relative accuracy of 4D dose accumulation for lung radiotherapy using rigid dose projection versus dose recalculation on every breathing phase.

artículo científico publicado en 2016

The treatment of early-stage disease.

artículo científico publicado en 2010

The world's first single-room proton therapy facility: Two-year experience

artículo científico publicado en 2016

Treatment of oligometastatic lung cancer with brain metastases using stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT)

scientific article published on 11 December 2019

Treatment of stage I non-small cell lung cancer: What's trending?

artículo científico publicado en 2017

Tumor control probability and the utility of 4D vs 3D dose calculations for stereotactic body radiotherapy for lung cancer

artículo científico publicado en 2014

Two-and-a-half-year clinical experience with the world's first magnetic resonance image guided radiation therapy system.

artículo científico publicado en 2017

WE-G-213CD-02: 4D-PET Maximum Intensity Projections Improve Accuracy of Mobile Tumor Volume Delineation.

artículo científico publicado en 2012

Lista de obras de Cliff G Robinson

A comparison of amplitude-based and phase-based positron emission tomography gating algorithms for segmentation of internal target volumes of tumors subject to respiratory motion.

A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: a decision analysis

A phase I study of temsirolimus and thoracic radiation in non--small-cell lung cancer

Adherence of US Insurance Payer Policies to the American Society of Radiation Oncology Stereotactic Radiosurgery Model Policy

Adjuvant Chemotherapy Is Associated With Improved Survival in Locally Invasive Node Negative Non-Small Cell Lung Cancer

Adjuvant Chemotherapy for Patients with T2N0M0 NSCLC

Analysis of first recurrence and survival in patients with stage I non-small cell lung cancer treated with surgical resection or stereotactic radiation therapy

Application of Critical Volume-Dose Constraints for Stereotactic Body Radiation Therapy in NRG Radiation Therapy Trials

Assessing margin expansions of internal target volumes in 3D and 4D PET: a phantom study.

Automated radiation therapy treatment plan workflow using a commercial application programming interface.

Bayesian network ensemble as a multivariate strategy to predict radiation pneumonitis risk

Benchmark Credentialing Results for NRG-BR001: The First National Cancer Institute-Sponsored Trial of Stereotactic Body Radiation Therapy for Multiple Metastases.

Brain Metastases at Presentation in Patients With Non-Small Cell Lung Cancer

Clinical T2N0 Esophageal Cancer: Identifying Pretreatment Characteristics Associated With Pathologic Upstaging and the Potential Role for Induction Therapy.

Clinical and Dosimetric Predictors of Acute Severe Lymphopenia During Radiation Therapy and Concurrent Temozolomide for High-Grade Glioma.

Defining the Ideal Time Interval Between Planned Induction Therapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer.

Delayed vertebral body collapse after stereotactic radiosurgery and radiofrequency ablation: Case report with histopathologic-MRI correlation

Distant intracranial failure in melanoma brain metastases treated with stereotactic radiosurgery in the era of immunotherapy and targeted agents

Dosimetric predictors of chest wall pain after lung stereotactic body radiotherapy

Effect of alternative temozolomide schedules on glioblastoma O(6)-methylguanine-DNA methyltransferase activity and survival.

Heart Dose Is an Independent Dosimetric Predictor of Overall Survival in Locally Advanced Non-Small Cell Lung Cancer

Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial

Impact of concurrent chemotherapy with radiation therapy for elderly patients with newly diagnosed glioblastoma: a review of the National Cancer Data Base

In Response to Treatment Outcomes in Stage I Lung Cancer: A Comparison of Surgery and Stereotactic Body Radiation Therapy.

In reply to Gondi and Mehta.

Independent test of a model to predict severe acute esophagitis.

Institutional Enrollment and Survival Among NSCLC Patients Receiving Chemoradiation: NRG Oncology Radiation Therapy Oncology Group (RTOG) 0617.

Intensity modulated radiation therapy for recurrent ovarian cancer refractory to chemotherapy.

It's never too late: Smoking cessation after stereotactic body radiation therapy for non-small cell lung carcinoma improves overall survival

Long-term survival and functional status of patients with low-grade astrocytoma of spinal cord.

Management of atypical cranial meningiomas, part 2: predictors of progression and the role of adjuvant radiation after subtotal resection

Modeling the impact of cardio-pulmonary irradiation on overall survival in NRG Oncology trial RTOG 0617

Motion-specific internal target volumes for FDG-avid mediastinal and hilar lymph nodes

Multi-Institutional Validation of a Knowledge-Based Planning Model for Patients Enrolled in RTOG 0617: Implications for Plan Quality Controls in Cooperative Group Trials

Multidisciplinary Treatment for Stage IIIA Non-Small Cell Lung Cancer: Does Institution Type Matter?

National Cancer Database Analysis of Proton Versus Photon Radiation Therapy in Non-Small Cell Lung Cancer

National patterns of care and outcomes after combined modality therapy for stage IIIA non-small-cell lung cancer

Neoadjuvant Chemotherapy versus Chemoradiation Prior to Esophagectomy: Impact on Rate of Complete Pathologic Response and Survival in Esophageal Cancer Patients

Online Magnetic Resonance Image Guided Adaptive Radiation Therapy: First Clinical Applications.

PET-based radiation therapy planning.

Patterns of care in hilar node-positive (N1) non-small cell lung cancer: A missed treatment opportunity?

Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non-small-cell lung cancer.

Pneumonectomy for Clinical Stage IIIA Non-Small Cell Lung Cancer: The Effect of Neoadjuvant Therapy.

Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the National Cancer Data Base

Postoperative single-fraction radiation for prevention of heterotopic ossification of the elbow

Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT)

Predictors of individual tumor local control after stereotactic radiosurgery for non-small cell lung cancer brain metastases.

Prospective study evaluating the use of IV contrast on IMRT treatment planning for lung cancer

Radiation Treatment Time and Overall Survival in Locally Advanced Non-small Cell Lung Cancer.

Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases.

Reply to C. Le Péchoux et al and B.S. Gill et al

Response to "Is post-operative radiotherapy of any benefit after R0 resection for N2 disease?".

Role for Surgical Resection in the Multidisciplinary Treatment of Stage IIIB Non-Small Cell Lung Cancer

SV40 large tumor antigen (T antigen): database of mutants ⬇️

Simulated Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Oligometastatic Disease of the Abdomen and Central Thorax: Characterization of Potential Advantages.

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two facto

Stereotactic body radiation therapy for the treatment of early-stage minimally invasive adenocarcinoma or adenocarcnioma in situ (formerly bronchioloalveolar carcinoma): a patterns of failure analysis.

Stereotactic body radiation therapy in the treatment of multiple primary lung cancers.

The Metastatic Spine Disease Multidisciplinary Working Group Algorithms.

The National Surgical Quality Improvement Program risk calculator does not adequately stratify risk for patients with clinical stage I non-small cell lung cancer

The Role of Surgical Resection in Stage IIIA Non-Small Cell Lung Cancer: A Decision and Cost-Effectiveness Analysis.

The relative accuracy of 4D dose accumulation for lung radiotherapy using rigid dose projection versus dose recalculation on every breathing phase.

The treatment of early-stage disease.

The world's first single-room proton therapy facility: Two-year experience

Treatment of oligometastatic lung cancer with brain metastases using stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT)

Treatment of stage I non-small cell lung cancer: What's trending?

Tumor control probability and the utility of 4D vs 3D dose calculations for stereotactic body radiotherapy for lung cancer

Two-and-a-half-year clinical experience with the world's first magnetic resonance image guided radiation therapy system.

WE-G-213CD-02: 4D-PET Maximum Intensity Projections Improve Accuracy of Mobile Tumor Volume Delineation.